In the BioHarmony Drug Report Database

"Preview" Icon

Rufinamide

Banzel, Inovelon (rufinamide) is a small molecule pharmaceutical. Rufinamide was first approved as Banzel on 2007-01-16. It is used to treat seizures in the USA. It has been approved in Europe to treat epilepsy. Banzel’s patent is valid until 2022-11-14 (FDA).

 

Trade Name

 

Inovelon
 

Common Name

 

rufinamide
 

ChEMBL ID

 

CHEMBL1201754
 

Indication

 

epilepsy, seizures
 

Drug Class

 

Image (chem structure or protein)

Rufinamide structure rendering